Conselium, an executive search firm, has completed a search for VP Ethics & Compliance on behalf of Actavis U.S. Mr. Michael Clarke joined Actavis U.S. in their Morristown, NJ office 1-30-2012.
Mr. Clarke’s Responsibilities include:
- Ensure consistency and alignment with the Global Ethics and Compliance program which includes America, Latin America and Canada.
- Conduct and coordinate the periodic risk assessments.
- Manage, design and implement education and training programs.
- Develop policies and procedures to avoid or minimize compliance risks.
- Coordinate and manage investigations of allegations concerning possible violations of the Ethical code, policies and procedures.
- Coordinate 3rd party due diligence and ensure the communication of compliance program to 3rd parties.
- Lead the reporting for HCP spending under federal and state law requirements.
- Liaise with Internal Audit function to determine compliance audit focus activities.
Mr. Clarke was previously VP Compliance Officer for Biomet. He also held executive compliance officer positions at the University of Medicine & Dentistry of New Jersey and Medco Health Solutions.
Actavis U.S. is the US manufacturing and marketing unit of global generics firm Actavis. The company makes a wide variety of generic equivalents of both prescription and OTC drugs, in a number of forms, including liquids, tablets, creams, and suppositories. Among other consumer and specialty drugs, it makes acetaminophen, ibuprofen, and generic Rogaine. It has also launched generic versions of Pfizer’s diabetes drug Glucotrol XL and GlaxoSmithKlein’s Coreg tables for hypertension and myocardial infarction. Actavis U.S. has manufacturing facilities in Maryland, New Jersey, and North Carolina, from which it ships its own products and provides contract manufacturing services to third parties. Actavis is one of the world’s leading players in the development, manufacture, and sale of first-class generic pharmaceuticals. The Group operates in over 40 countries around the globe. With a US portfolio that includes more than 150 pharmaceutical products, we strive to continually offer new solutions in affordable healthcare
Published by Conselium Executive Search, the global leader in compliance search.
